Jpmorgan Chase & Co »

Dare Bioscience shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Dare Bioscience (DARE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Dare Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Dare Bioscience held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dare Bioscience by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8k 12k 0.31
2023-09-30 $47 104 0.46
2023-03-31 $10k 9.4k 1.07
2018-12-31 $0 239 0.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Dare Bioscience

Vanguard Group
T. Rowe Price Associates
Founders Financial Securities
Commonwealth Equity Services
Wealth Enhancement Advisory Services
Charles Schwab Investment Management
Objectivity Squared
Susquehanna International
Asset Management Investors
Bank of New York Mellon
Raymond James Financial Services Advisors
Advisory Services Network
Virtu Financial
Jpmorgan Chase & Co
First Affirmative Financial Network

View all funds holding Dare Bioscience